Alibaba Health Information Technology (HKG:0241) recorded a rise in attributable profit to 1.94 billion yuan in the year ended March 31, up from 1.43 billion yuan a year prior.

Earnings per share rose to 0.1195 yuan from 0.0888 yuan in the previous fiscal year, according to a Thursday Hong Kong bourse filing.

Revenue jumped to 34.26 billion yuan from 30.6 billion yuan in the year-ago period, thanks mainly to the development of the pharmaceutical direct sales business, as well as healthcare and digital services.

The board recommended a final dividend of 0.0595 yuan per share and a special dividend of 0.1352 yuan for the year, payable Sept. 2 to shareholders of record on Aug. 13, subject to shareholders approval.